Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123031083 | 12303108 | 3 | F | 2007 | 20160606 | 20160426 | 20160830 | PER | US-JNJFOC-20160320943 | JANSSEN | 0.00 | C | M | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123031083 | 12303108 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 3 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 4 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 5 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 6 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 7 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 8 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 9 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 10 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 11 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 12 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 13 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 14 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 123031083 | 12303108 | 15 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 20272 | TABLETS | ||||||||
| 123031083 | 12303108 | 16 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | 1 | MG | UNSPECIFIED | |||||||
| 123031083 | 12303108 | 17 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | 1 | MG | UNSPECIFIED | |||||||
| 123031083 | 12303108 | 18 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 20272 | 1 | MG | UNSPECIFIED | |||||||
| 123031083 | 12303108 | 19 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | TABLETS | |||||||||
| 123031083 | 12303108 | 20 | SS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Unknown | U | 0 | 15 | MG | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123031083 | 12303108 | 1 | Abnormal behaviour |
| 123031083 | 12303108 | 2 | Abnormal behaviour |
| 123031083 | 12303108 | 3 | Abnormal behaviour |
| 123031083 | 12303108 | 4 | Abnormal behaviour |
| 123031083 | 12303108 | 5 | Abnormal behaviour |
| 123031083 | 12303108 | 6 | Attention deficit/hyperactivity disorder |
| 123031083 | 12303108 | 7 | Attention deficit/hyperactivity disorder |
| 123031083 | 12303108 | 8 | Attention deficit/hyperactivity disorder |
| 123031083 | 12303108 | 9 | Attention deficit/hyperactivity disorder |
| 123031083 | 12303108 | 10 | Attention deficit/hyperactivity disorder |
| 123031083 | 12303108 | 11 | Autism |
| 123031083 | 12303108 | 12 | Autism |
| 123031083 | 12303108 | 13 | Autism |
| 123031083 | 12303108 | 14 | Autism |
| 123031083 | 12303108 | 15 | Autism |
| 123031083 | 12303108 | 16 | Abnormal behaviour |
| 123031083 | 12303108 | 17 | Attention deficit/hyperactivity disorder |
| 123031083 | 12303108 | 18 | Autism |
| 123031083 | 12303108 | 19 | Product used for unknown indication |
| 123031083 | 12303108 | 20 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123031083 | 12303108 | Chest pain | |
| 123031083 | 12303108 | Emotional disorder | |
| 123031083 | 12303108 | Gynaecomastia | |
| 123031083 | 12303108 | Obesity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123031083 | 12303108 | 1 | 200704 | 200806 | 0 | |
| 123031083 | 12303108 | 2 | 2005 | 0 | ||
| 123031083 | 12303108 | 3 | 2008 | 0 | ||
| 123031083 | 12303108 | 4 | 2005 | 2012 | 0 | |
| 123031083 | 12303108 | 5 | 2004 | 2008 | 0 | |
| 123031083 | 12303108 | 6 | 2005 | 2012 | 0 | |
| 123031083 | 12303108 | 7 | 2008 | 0 | ||
| 123031083 | 12303108 | 8 | 200704 | 200806 | 0 | |
| 123031083 | 12303108 | 9 | 2005 | 0 | ||
| 123031083 | 12303108 | 10 | 2004 | 2008 | 0 | |
| 123031083 | 12303108 | 11 | 200704 | 200806 | 0 | |
| 123031083 | 12303108 | 12 | 2005 | 0 | ||
| 123031083 | 12303108 | 13 | 2004 | 2008 | 0 | |
| 123031083 | 12303108 | 14 | 2005 | 2012 | 0 | |
| 123031083 | 12303108 | 15 | 2008 | 0 | ||
| 123031083 | 12303108 | 16 | 2008 | 2012 | 0 | |
| 123031083 | 12303108 | 17 | 2008 | 2012 | 0 | |
| 123031083 | 12303108 | 18 | 2008 | 2012 | 0 | |
| 123031083 | 12303108 | 20 | 2004 | 2008 | 0 |